The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 28, 2021
Filed:
Sep. 13, 2019
Applicants:
Beth Israel Deaconess Medical Center, Inc., Boston, MA (US);
The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);
Inventors:
Kun Ping Lu, Newton, MA (US);
Matthew Brian Boxer, Rockville, MD (US);
Mindy Irene Emily Davis, Rockville, MD (US);
Rajan Pragani, Rockville, MD (US);
Min Shen, Rockville, MD (US);
Anton Momtchilov Simeonov, Rockville, MD (US);
Shuo Wei, Chestnut Hill, MA (US);
Xiao Zhen Zhou, Newton, MA (US);
Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61K 31/473 (2006.01); A61K 31/185 (2006.01); A61K 31/341 (2006.01); A61K 31/357 (2006.01); A61K 31/365 (2006.01); A61K 31/381 (2006.01); A61K 31/382 (2006.01); A61K 31/402 (2006.01); A61K 31/4025 (2006.01); A61K 31/404 (2006.01); A61K 31/405 (2006.01); A61K 31/4245 (2006.01); A61K 31/427 (2006.01); A61K 31/428 (2006.01); A61K 31/4704 (2006.01); A61K 31/496 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 31/185 (2013.01); A61K 31/341 (2013.01); A61K 31/357 (2013.01); A61K 31/365 (2013.01); A61K 31/381 (2013.01); A61K 31/382 (2013.01); A61K 31/402 (2013.01); A61K 31/404 (2013.01); A61K 31/405 (2013.01); A61K 31/4025 (2013.01); A61K 31/427 (2013.01); A61K 31/428 (2013.01); A61K 31/4245 (2013.01); A61K 31/473 (2013.01); A61K 31/4704 (2013.01); A61K 31/496 (2013.01); A61K 45/06 (2013.01);
Abstract
The invention features compositions and methods for inhibiting the Pin1 protein, and the treatment of disorders characterized by elevated Pin1 levels.